AP
BRKR icon

Antipodes Partners’s Bruker BRKR Stock Holding History

Antipodes Partners’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
20,145
-3,168
-14% -$148K 0.02% 80
2026
Q1 		$842K Buy
23,313
+10,163
+77% +$425K 0.02% 78
2025
Q4 		$620K Buy
13,150
+4,982
+61% +$211K 0.01% 76
2025
Q3 		$265K Buy
8,168
+1,380
+20% +$49.2K 0.01% 76
2025
Q2 		$280K Buy
6,788
+1,706
+34% +$65.9K 0.01% 59
2025
Q1 		$212K Buy
+5,082
New +$264K 0.01% 58

Other funds holding BRKR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Antipodes Partners's BRKR Position: Q2 2026 in Review

Antipodes Partners reduced its Bruker (BRKR) stake by 14% in Q2 2026, selling an estimated $148K and leaving 20,145 shares worth $1.21M. The position accounts for 0.02% of the portfolio, ranked #80.

Antipodes Partners first reported a position in BRKR in Q1 2025 and has held it in 6 quarters since. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Antipodes Partners held 20,145 shares of Bruker worth $1.21M as of Q2 2026.
  • Antipodes Partners sold 3,168 Bruker shares in Q2 2026, an estimated $148K.
  • Bruker made up 0.02% of Antipodes Partners's portfolio in Q2 2026, its #80 holding.
  • Antipodes Partners first reported a position in Bruker in Q1 2025 and has held it in 6 quarters since.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.